Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

316 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis.
Montalban X, Arnold DL, Weber MS, Staikov I, Piasecka-Stryczynska K, Willmer J, Martin EC, Dangond F, Syed S, Wolinsky JS; Evobrutinib Phase 2 Study Group. Montalban X, et al. Among authors: martin ec. N Engl J Med. 2019 Jun 20;380(25):2406-2417. doi: 10.1056/NEJMoa1901981. Epub 2019 May 10. N Engl J Med. 2019. PMID: 31075187 Clinical Trial.
Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study.
Abraham E, Reinhart K, Svoboda P, Seibert A, Olthoff D, Dal Nogare A, Postier R, Hempelmann G, Butler T, Martin E, Zwingelstein C, Percell S, Shu V, Leighton A, Creasey AA. Abraham E, et al. Crit Care Med. 2001 Nov;29(11):2081-9. doi: 10.1097/00003246-200111000-00007. Crit Care Med. 2001. PMID: 11700399 Clinical Trial.
Screening of a kinase inhibitor library identified novel targetable kinase pathways in triple-negative breast cancer.
Rinderle CH, Baker CV, Lagarde CB, Nguyen K, Al-Ghadban S, Matossian MD, Hoang VT, Martin EC, Collins-Burow BM, Ali S, Drewry DH, Burow ME, Bunnell BA. Rinderle CH, et al. Among authors: martin ec. Anticancer Drugs. 2025 Jan 1;36(1):39-48. doi: 10.1097/CAD.0000000000001658. Epub 2024 Aug 21. Anticancer Drugs. 2025. PMID: 39671264 Free PMC article.
Context-Dependent Estrogenic Actions of (+)-Pisatin Produced in Elicited Green or Snow Pea (Pisum sativum).
Belgodere JA, Benz MC, Kpeli GW, Elliott JR, Elliott S, North JD, Ponder IJ, Ma P, Dietrich SR, Cheng T, Nguyen K, Tilghman SL, McLachlan JA, Zou B, Anbalagan M, Rowan B, Mondrinos M, Wiese TE, Hoang VT, Collins-Burow BM, Martin EC, Burow ME, Boué SM. Belgodere JA, et al. Among authors: martin ec. J Agric Food Chem. 2024 Dec 25;72(51):28255-28269. doi: 10.1021/acs.jafc.4c06409. Epub 2024 Dec 12. J Agric Food Chem. 2024. PMID: 39665386
Obesity and leptin in breast cancer angiogenesis.
Lagarde CB, Thapa K, Cullen NM, Hawes ML, Salim K, Benz MC, Dietrich SR, Burow BE, Bunnell BA, Martin EC, Collins-Burow BM, Lynch RM, Hoang VT, Burow ME, Fang JS. Lagarde CB, et al. Among authors: martin ec. Front Endocrinol (Lausanne). 2024 Oct 8;15:1465727. doi: 10.3389/fendo.2024.1465727. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39439572 Free PMC article. Review.
316 results